These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25552727)

  • 41. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.
    Bracco Neto H; Farhat CK; Tregnaghi MW; Madhi SA; Razmpour A; Palladino G; Small MG; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2009 May; 28(5):365-71. PubMed ID: 19395948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. H5N1 influenza A virus with K193E and G225E double mutations in haemagglutinin is attenuated and immunogenic in mice.
    Han PF; Li J; Hu Y; Sun W; Zhang S; Yang YH; Li YC; Kang XP; Wu XY; Zhu SY; Zhang Y; Zhu QY; Qin CF; Jiang T
    J Gen Virol; 2015 Sep; 96(9):2522-2530. PubMed ID: 25998916
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
    Belshe RB; Mendelman PM; Treanor J; King J; Gruber WC; Piedra P; Bernstein DI; Hayden FG; Kotloff K; Zangwill K; Iacuzio D; Wolff M
    N Engl J Med; 1998 May; 338(20):1405-12. PubMed ID: 9580647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Establishment of memory CD8+ T cells with live attenuated influenza virus across different vaccination doses.
    Wang Z; Kedzierski L; Nuessing S; Chua BYL; Quiñones-Parra SM; Huber VC; Jackson DC; Thomas PG; Kedzierska K
    J Gen Virol; 2016 Dec; 97(12):3205-3214. PubMed ID: 27902386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells.
    Wohlgemuth N; Ye Y; Fenstermacher KJ; Liu H; Lane AP; Pekosz A
    Vaccine; 2017 Dec; 35(48 Pt B):6691-6699. PubMed ID: 29079099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-Based Attenuation of Influenza Virus across Susceptible Hosts.
    Waring BM; Sjaastad LE; Fiege JK; Fay EJ; Reyes I; Moriarity B; Langlois RA
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093096
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
    Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
    Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    Hughes HR; Brockmeier SL; Loving CL
    Front Immunol; 2018; 9():2255. PubMed ID: 30337924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults.
    Karron RA; Callahan K; Luke C; Thumar B; McAuliffe J; Schappell E; Joseph T; Coelingh K; Jin H; Kemble G; Murphy BR; Subbarao K
    J Infect Dis; 2009 Mar; 199(5):711-6. PubMed ID: 19210163
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
    Nichol KL; Mendelman PM; Mallon KP; Jackson LA; Gorse GJ; Belshe RB; Glezen WP; Wittes J
    JAMA; 1999 Jul; 282(2):137-44. PubMed ID: 10411194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immunological effectiveness of a method for simultaneous immunization against influenza using live and inactivated vaccines].
    Orlov VA; Zhilova GP; Ignat'eva GS; Malikova EV; Efremov BV
    Vopr Virusol; 1982; 27(3):271-5. PubMed ID: 7123907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children.
    Breiman RF; Brooks WA; Goswami D; Lagos R; Borja-Tabora C; Lanata CF; Londoño JA; Lum LC; Rappaport R; Razmpour A; Walker RE; Gruber WC; Forrest BD
    Vaccine; 2009 Sep; 27(40):5472-9. PubMed ID: 19616493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
    Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preliminary results of oral influenza vaccination with live attenuated viruses.
    DeBarbieri A; Crovari P; Cuneo-Crovari P; Badolati G; Giacometti G
    Dev Biol Stand; 1976; 33():213-9. PubMed ID: 782972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care Center.
    Clements ML; Makhene MK; Karron RA; Murphy BR; Steinhoff MC; Subbarao K; Wilson MH; Wright PF
    J Infect Dis; 1996 Jan; 173(1):44-51. PubMed ID: 8537681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates.
    Matsuoka Y; Suguitan A; Orandle M; Paskel M; Boonnak K; Gardner DJ; Feldmann F; Feldmann H; Marino M; Jin H; Kemble G; Subbarao K
    J Virol; 2014 Jul; 88(14):8139-52. PubMed ID: 24807726
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Vaccinal prevention of influenza in children].
    Zykov MP; Vasil'eva RI
    Tr Inst Im Pastera; 1982; 58():30-8. PubMed ID: 6764981
    [No Abstract]   [Full Text] [Related]  

  • 59. The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing.
    Ambrose CS; Dubovsky F; Yi T; Belshe RB; Ashkenazi S
    Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2549-57. PubMed ID: 22410646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Canine influenza viruses with modified NS1 proteins for the development of live-attenuated vaccines.
    Nogales A; Huang K; Chauché C; DeDiego ML; Murcia PR; Parrish CR; Martínez-Sobrido L
    Virology; 2017 Jan; 500():1-10. PubMed ID: 27750071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.